Evidence map›Paper›PMID 37298679›Full record

ReviewInternational journal of molecular sciences2023

Co-Expression of Podoplanin and CD44 in Proliferative Vitreoretinopathy Epiretinal Membranes.

Denise Bonente, Laura Bianchi, Rossana De Salvo, Claudio Nicoletti, Elena De Benedetto, Tommaso Bacci, Luca Bini, Giovanni Inzalaco, Lorenzo Franci, Mario Chiariello and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Proliferative Vitreoretinopathy: A Reappraisal.Journal of clinical medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Denise BonenteDepartment of Life Sciences, University of Siena, Via A. Moro 2, 53100 Siena, Italy.ORCID 0000-0002-3080-6406
Laura BianchiSection of Functional Proteomics, Department of Life Sciences, University of Siena, Via A. Moro 2, 53100 Siena, Italy.ORCID 0000-0001-9219-1227
Rossana De SalvoSection of Functional Proteomics, Department of Life Sciences, University of Siena, Via A. Moro 2, 53100 Siena, Italy.
Claudio NicolettiDepartment of Molecular and Developmental Medicine, University of Siena, Via A. Moro 2, 53100 Siena, Italy.
Elena De BenedettoDepartment of Medicine, Surgery and Neuroscience, University of Siena, Viale Mario Bracci 16, 53100 Siena, Italy.
Tommaso BacciDepartment of Medicine, Surgery and Neuroscience, University of Siena, Viale Mario Bracci 16, 53100 Siena, Italy.ORCID 0000-0001-7477-2263
Luca BiniSection of Functional Proteomics, Department of Life Sciences, University of Siena, Via A. Moro 2, 53100 Siena, Italy.ORCID 0000-0001-8951-2106
Giovanni InzalacoCore Research Laboratory (CRL), Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Via Fiorentina 1, 53100 Siena, Italy.ORCID 0000-0002-1663-1857
Lorenzo FranciCore Research Laboratory (CRL), Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Via Fiorentina 1, 53100 Siena, Italy.ORCID 0000-0001-6300-1746
Mario ChiarielloCore Research Laboratory (CRL), Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Via Fiorentina 1, 53100 Siena, Italy.ORCID 0000-0001-8434-5177
Gian Marco TosiDepartment of Medicine, Surgery and Neuroscience, University of Siena, Viale Mario Bracci 16, 53100 Siena, Italy.
Eugenio BertelliDepartment of Molecular and Developmental Medicine, University of Siena, Via A. Moro 2, 53100 Siena, Italy.ORCID 0000-0002-9681-4556
Virginia BaroneDepartment of Molecular and Developmental Medicine, University of Siena, Via A. Moro 2, 53100 Siena, Italy.ORCID 0000-0001-8794-9291
University of Siena · ITIstituto per lo Studio e la Prevenzione Oncologica · IT

Funding

University of Siena University of Siena, grant 2267-2022-BV-PAR_001 to V.B.
6 · The paper itself

Abstract

Epiretinal membranes (ERMs) are sheets of tissue that pathologically develop in the vitreoretinal interface leading to progressive vision loss. They are formed by different cell types and by an exuberant deposition of extracellular matrix proteins. Recently, we reviewed ERMs' extracellular matrix components to better understand molecular dysfunctions that trigger and fuel the onset and development of this disease. The bioinformatics approach we applied delineated a comprehensive overview on this fibrocellular tissue and on critical proteins that could really impact ERM physiopathology. Our interactomic analysis proposed the hyaluronic-acid-receptor cluster of differentiation 44 (CD44) as a central regulator of ERM aberrant dynamics and progression. Interestingly, the interaction between CD44 and podoplanin (PDPN) was shown to promote directional migration in epithelial cells. PDPN is a glycoprotein overexpressed in various cancers and a growing body of evidence indicates its relevant function in several fibrotic and inflammatory pathologies. The binding of PDPN to partner proteins and/or its ligand results in the modulation of signaling pathways regulating proliferation, contractility, migration, epithelial-mesenchymal transition, and extracellular matrix remodeling, all processes that are vital in ERM formation. In this context, the understanding of the PDPN role can help to modulate signaling during fibrosis, hence opening a new line of therapy.

Indexed as

Epiretinal MembraneVitreoretinopathy, ProliferativeExtracellular Matrix ProteinsFibrosisHumansHyaluronan ReceptorsPodoplaninTranscription FactorsCD44 protein, humanExtracellular Matrix ProteinsHyaluronan ReceptorsPDPN protein, humanPodoplaninTranscription Factorscell migrationcluster of differentiation 44 (CD44)epiretinal membrane (ERM)fibrosisinteractomicspodoplanin (PDPN)proliferative vitreoretinopathytransdifferentiation

Identifiers

PMID37298679
PMCPMC10253751
OpenAlexW4379527667

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.